Myocarditis in SARS-CoV-2: A Meta-Analysis
Ranel Thaker1, James Faraci2, Sierra Derti1
1Internal Medicine, Lake Erie College of Osteopathic Medicine, Elmira, USA.
Insights
COVID-19 infection significantly increases myocarditis risk in unvaccinated individuals. However, COVID-19 vaccination does not show a statistically significant increased risk for myocarditis compared to the uninfected population. Further research is warranted.
Area of Science:
- Cardiology
- Infectious Diseases
- Vaccinology
- Epidemiology
Background:
- A notable increase in cardiovascular events, including myocarditis, has been observed following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the virus responsible for coronavirus disease 2019 (COVID-19).
- Reports indicate a rise in myocarditis cases among individuals infected with SARS-CoV-2 and those who received COVID-19 mRNA vaccines, necessitating a clear understanding of the associated risks.
Purpose of the Study:
- To quantitatively assess and compare the risk of myocarditis associated with SARS-CoV-2 infection versus COVID-19 vaccination.
- To elucidate the specific risks of myocarditis in unvaccinated versus vaccinated populations in relation to COVID-19.
Main Methods:
- A comprehensive literature search was conducted across PubMed, Google Scholar, and the WHO Global Literature on Coronavirus Disease.
- Relevant randomized controlled trials and cohort studies detailing myocarditis risk from SARS-CoV-2 infection and COVID-19 vaccines were selected.
- A meta-analysis was performed using the inverse variance method with RevMan software to synthesize the compiled data.
Main Results:
- Meta-analysis revealed a significantly higher risk of myocarditis in individuals with COVID-19 infection (Risk Ratio = 5.01, 95% CI = 4.14–6.08) compared to the non-infected population.
- A significant difference in myocarditis risk was observed in those with unspecified vaccination status compared to the non-infected (Risk Ratio = 4.74, 95% CI = 2.40–9.36).
- No statistically significant difference in myocarditis risk was found between vaccinated individuals and the non-infected population (Risk Ratio = 2.55, 95% CI = 0.84–7.74).
Conclusions:
- SARS-CoV-2 infection in unvaccinated individuals is associated with a statistically significant increased risk of developing myocarditis.
- Individuals receiving the COVID-19 vaccine do not exhibit a statistically significant increased risk of myocarditis compared to the uninfected population.
- The findings underscore the importance of vaccination in mitigating the risk of myocarditis associated with COVID-19.
Abstract:
There has been a rise in cardiovascular events following the onset of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, a strain that caused coronavirus disease 2019 (COVID-19). Although rare, there has been an increase in reports of myocarditis secondary to both individuals infected by the strain and those who received the COVID-19 mRNA vaccine. The focus of this study is to determine the risk of myocarditis associated with the COVID-19 vaccine and SARS-CoV-2 infection. Relevant literature was collected using the search engines PubMed, Google Scholar, and the WHO Global Literature on Coronavirus Disease. Randomized controlled clinical trials and cohort studies reporting the risk of myocarditis induced by SARS-CoV-2 infection and COVID-19 vaccines were used. A meta-analysis was conducted using the inverse variance method using RevMan application software. A meta-analysis of the compiled data showed a mean risk ratio of 4.74 (95% confidence interval (CI) = 2.40 to 9.36; p < 0.0000100), which indicates there is a significant difference in the risk of COVID-19-induced myocarditis in those with unspecified vaccination status compared to the non-infected population. A meta-analysis of the selected data found a mean risk ratio of 5.01 (95% CI = 4.14 to 6.08; p < 0.0000100), indicating a significant difference in the risk of COVID-19-induced myocarditis between those who are unvaccinated and the non-infected population. Upon a meta-analysis of the selected data set, a mean risk ratio of 2.55 (95% CI = 0.840 to 7.74; p = 0.100) was found, indicating no significant difference in the risk of vaccine-induced myocarditis between those with a vaccinated vaccination status and that of the non-infected population. The result of this meta-analysis showed that infection with SARS-CoV-2 in unvaccinated patients carries a statistically significant increased risk of acquiring myocarditis while those receiving the vaccination do not share this same risk.
More Related Videos
07:35Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
Published on: December 10, 2021
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Coronavirus
Genital Herpes
